GT-001 (PentixaPharm)

N/A

Report date: 2026/01/13 11:24:23

Base Information

Drug NameGT-001 (PentixaPharm)
Drug Alias NameGT-001GT-001(PentixaPharm)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionLewis-Y antigen modulators
TargetsLewis-Y antigen
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPentixapharm AG
China Registration ClassN/A

Develop Information

Active CompaniesPentixapharm AGMax Delbrück Center For Molecular Medicine
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A